RWD-based Simulations: Generating Medical Evidence from Clinical Trial and Real-World Data
Real-world data (RWD)-based simulations use the insights derived from randomized control trials to patient populations seen in routine clinical practice and assess the impact of treatment strategies on patient outcomes.
The case study described in the above white paper helped identify appropriate target populations for a newly launched therapy, and resultingly, impacted clinical practice guidelines. With growing recognition and appreciation of RWE studies, additional applications of RWD-based simulations can extend to market access, safety and efficacy studies, and regulatory submissions.
Click here to download the white paper.